Professional
Added to YB: 2024-10-22
Pitch date: 2024-09-30
REGN [bullish]
Regeneron Pharmaceuticals, Inc.
-27.12%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
Market Cap
$78.2B
Pitch Price
$1.0K
Price Target
N/A
Dividend
0.49%
EV/EBITDA
14.55
P/E
18.37
EV/Sales
4.34
Sector
Biotechnology
Category
growth
Show full summary:
Baron Health Care Fund New Position: Regeneron Pharmaceuticals, Inc.
REGN: Biopharma leader w/ blockbusters Eylea/Eylea HD (retinal) & Dupixent (immunological). Eylea facing patent expiry, but HD version & Dupixent growing. 35+ pipeline candidates incl. food allergy, cancer, blood clot prevention. Strong R&D track record suggests pipeline success, driving potential upside.
Read full article (1 min)